Skip to main content
OpenTrials
Completed

NCT Number: NCT00917566

Evaluation of Airtraq in Pediatric

This study indented to evaluate the use of Optical laryngoscope in pediatric

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

2 year–10 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

king Khaled Eye Specialist hospital

Riyadh, Riyadh Region, 11462, Saudi Arabia

About this study

The authors are welling to study how intubation will differ if Airtraq optical laryngoscope used in pediatrics

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy children undergoing general anesthesia required tracheal intubation.

Exclusion criteria

  • History of difficult intubation.
  • Risk of aspiration.
  • Children with cardiovascular disease.
  • Children with respiratory disease.

Treatment and study plan

Airtraq

Device

intubation with airtraq

Other names: Optical laryngoscope

Macintoch

Device

use Macintoch laryngoscope for intubation

Other names: Standard laryngoscope

Primary outcomes

  1. Duration of intubation

    Time frame: two minutes

Sponsors and collaborators

Lead sponsor

King Khaled Eye Specialist Hospital

Other Gov

Registry information

Official study title

Evaluation of Airtraq in Pediatric Population: A Prospective Randomized Study

Important dates

Study start
2009
Primary completion
2009
Study completion
2009
First posted
Jun 10, 2009
Registry last updated
Nov 19, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.